With the presence of an important group of artists who are participating in the Festival Artes de Cuba these days, an event was held in the Cuban Embassy in Washington D.C. to acknowledge the holding of this Festival, the largest of its kind to be held in the United States, and the work of the John F. Kennedy Center in organize it.
The Ambassador of Cuba in Washington D.C., José Ramón Cabañas, paid a working visit to Florida on April 9- 10.
The high-ranking official had the opportunity to meet with businesspersons from several companies with contracts in Cuba, in particular, with those from the transportation sector, which in 2017, transported more than one million passengers to the Island from the United States.
The Cuban company Heber Biotec and the U.S. company Mercurio Biotec join efforts to bring Heberprot-P therapy to patients who suffer from diabetic foot ulcer (DFU) in the United States, upon approval from the U.S. Food and Drug Administration (FDA).
According to the press note released by the entrepreneurial group BioCubaFarma, the Cuban therapy is expected to lower in more than half the current figure of risk of diabetic foot ulcer-related amputations in the United States, due to the successful history of the product and the commitment given by Mercurio and Heber.